Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

The XBB.1.5 subvariant — nicknamed ‘Kraken ... and how the PBS NewsHour covered them. After a year, omicron still driving COVID surges amid holiday season The omicron variant is driving ...

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

This year’s COVID-19 booster was rolled out in doctors offices and pharmacies in September, and attempts to address the rise ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

The CDC has just announced a second shot for elders and the immunocompromised people – but when’s the best time?

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Australian Department of Health statistics showed 72.3 million doses of the COVID-19 vaccine had been administered as of October 9. Pfizer's Omicron XBB. 1.5 and original vaccines were approved ...

Seasonal influenza and COVID-19 vaccination uptake for risk groups such as the elderly were sub-optimal in several EU/EEA ...

Prior to Health Canada's latest approval, Canadians had the option to receive a booster of the previous formulation that targets Omicron XBB.1.5. However, these are updated vaccines that replace those ...